Key result
This review outlines strategies for risk prediction and avoiding complications in chronic total occlusion percutaneous coronary intervention to facilitate shared decision making.
Why the study?
Chronic total occlusion (CTO) PCI carries higher complication rates than non-CTO PCI, necessitating review of risk prediction and complication-avoidance strategies.
Identifying patients at increased risk of periprocedural MACE during CTO PCI is crucial for shared decision-making regarding the risks and benefits of the procedure.
Risk scores may aid CTO PCI planning and complication avoidance; leaves open prospective validation before routine adoption.
INTRODUCTION: Angina refractory to medical therapy and providing complete revascularization (after acute coronary syndrome or in patients with ischemic cardiomyopathy) are common indications for chronic total occlusion (CTO) percutaneous coronary intervention (PCI). Unfortunately, CTO PCI is associated with higher rates of complications when compared with non-CTO PCI. AREAS COVERED: In this article, we review available studies on risk prediction in CTO PCI and outline strategies to avoid complications. EXPERT OPINION: Identifying patients at increased risk of periprocedural major adverse cardiovascular events (MACE) is of great importance. It enhances the conversations about the risk and benefits of CTO PCI and it allows for shared decision making when deciding to undergo or forego such procedures.
No takes yet. Share an insight, caveat, or question.
Neupane et al. (2020) conducted a review in Chronic total occlusion. Chronic total occlusion percutaneous coronary intervention (CTO PCI) was evaluated. This review outlines strategies for risk prediction and avoiding complications in chronic total occlusion percutaneous coronary intervention to facilitate shared decision making.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: